Abstract:Objective To investigate the safety and efficacy of MgSO4 infusion on symptomatic vasospasm and functional outcome in patients with aneurysmal SAH. Methods 39 patients were enrolled in the study winthin 48 hours following aneurysmal SAH. Patients were randomly located to saline infusion( group A) and intravenous MgSO4 40 mL/day ( group B) , 80 mL/day (group C ) for 14 days. Magnesium concentration, blood pressure and the mean flow velocity of MCA were checked for 14 days. Disability and the long-term functional outcomes were assessed by GOSE, Modified Ranking Scale. Results symptomatic vasospasm occurred 17 of 39 patients,7 patients in group A,5 patients in group B,5 patiets in group C; patients with symptomatic vasospasm receiving MgSO4 have better functional recovery and an improved score in GOSE 6 months follow-up. However, none of these outcomes variable reach a statistically significant level. Conclusion Administration of MgSO4 following aneurysmal SAH is safe and steady Mg2 + levels are easily maintained. This treatment may be useful in producing better outcomes. A larger study is required to confirm the effect of MgSO4.

Intravenous magnesium sulfate in aneurysmal subarachnoid hemorrhage